Skip to content

Feasibility study to assess the impact of the Fimo-Health app on quality of life and health competency of patients with rheumatoid arthritis

Feasibility study to assess the impact of the Fimo-Health app on quality of life and health competency of patients with rheumatoid arthritis - Fima-Impact-RA

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00035194
Enrollment
30
Registered
2024-10-01
Start date
2024-08-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M06

Interventions

Group 1: 1 study arm = intervention group Probands with rheumatoid arthritis using the Fimo-Health App

Sponsors

Uniklinik Erlangen
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with rheumatoid arthritis who fulfill the ACR/EULAR classification crite.ria, written informed consent.

Exclusion criteria

Exclusion criteria: No signed declaration of consent, change of medication in the last 3 months.

Design outcomes

Primary

MeasureTime frame
1. Can quality of life be improved in patients with rheumatoid arthritis using the Fimo Health App? 2. How does fatigue change when using the Fimo Health app in patients with rheumatoid arthritis? 3. Can pain be reduced in patients with rheumatoid arthritis using the Fimo Health app?

Secondary

MeasureTime frame
1. Is there an improvement in health and exercise competency using the Fimo-Health app in patients with rheumatoid arthritis? 2. How does the Fimo-Health app affect fear of movement in patients with rheumatoid arthritis? 3. Is the Fimo-Health app user-friendly for patients with rheumatoid arthritis? 4. What is the acceptance of the Fimo-Health app among patients with rheumatoid arthritis? 5. Is the FimoHealth app used regularly and what content is the main focus?

Countries

Germany

Contacts

Public ContactHarriet Morf

Uniklinik

harriet.morf@uk-erlangen.de091318543023

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026